Sara Elena Rebuzzi։ Using AI to Predict Immunotherapy Outcomes in Metastatic Renal Cell Carcinoma
Sara Elena Rebuzzi, Medical Oncologist, MD, PhD at A.O.U. Città della Salute e della Scienza di Torino, shared on LinkedIn: “Great collaboration on the use of Artificial Intelligence for assessing […]
Read the full articleYou might also wanna read
Los científicos de los Institutos Nacionales de la Salud crearon una herramienta de inteligencia artificial para pronosticar la respuesta de los pacientes de cáncer a la inmunoterapia
Una herramienta de inteligencia artificial (IA) creada por los investigadores del Instituto Nacional del Cáncer usa datos clínicos habituale
How AI is reshaping oncologists' trust in their own clinical judgment
Oncologists spend years learning to trust their own judgment, an ability that marries intuition with reasoning. What happens to that hard-wo
mdsc.pe·22d agoResearch on AI Models for Predicting Breast Cancer Treatment Effectiveness to Guide Her-2 Targeted ADC Therapy
Conditions : Breast Cancer Sponsors : Zhejiang Cancer Hospital Not yet recruiting
La IA identifica a los pacientes en los que funcionará la inmunoterapia contra el cáncer
Expertos de la Universidad de Harvard (Cambridge, Estados Unidos) han desarrollado un nuevo modelo de inteligencia artificial (IA) que utili
Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
Conditions : Oncology Interventions : Behavioral: HIIT Sponsors : Radboud University Medical Center Not yet recruiting
Comments
Sign in to join the conversation.
No comments yet. Be the first.